PreClinOmics, Inc. Our company has undergone significant growth since its incorporation and is becoming the preclinical contract research company of choice for scientists involved in drug discovery research. It specializes in the design and execution of compound efficacy, PK/PD, ADME and early safety studies in therapeutic areas such as metabolic syndrome, obesity, diabetes, cardiovascular anomalies, renal failure, neurology and cancer. Occupying over 23,000 sqft of space, the company has the capacity to quickly respond to a sponsor’s request for initiating a study. From the time of initial contact to data finalization the constant and seamless level of communication supports our commitment to everything being sponsor driven. OUr company constantly strives to maintain a technological edge so that our sponsors have access to a broad range of services to support their preclinical drug discovery research efforts. Technologies include QNMR, telemetry, LC/MS, and the latest multiplexing capabilities with MesoScale Discovery, Luminex and Rules Based Medicine.